Connection

Alicia Jenkins to Middle Aged

Back to Details
This is a "connection" page, showing publications Alicia Jenkins has written about Middle Aged.
Alicia Jenkins
Connection Strength
1.064
Middle Aged
  1. Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes. Sci Rep. 2021 09 21; 11(1):18708.
    View in: PubMed
    Score: 0.055
  2. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021 07 09; 11(1):14182.
    View in: PubMed
    Score: 0.055
  3. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Sci Rep. 2021 06 03; 11(1):11727.
    View in: PubMed
    Score: 0.054
  4. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study. J Clin Endocrinol Metab. 2020 10 01; 105(10).
    View in: PubMed
    Score: 0.052
  5. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Res Clin Pract. 2020 Sep; 167:108359.
    View in: PubMed
    Score: 0.051
  6. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common. Intern Med J. 2018 09; 48(9):1080-1086.
    View in: PubMed
    Score: 0.045
  7. Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. J Diabetes Complications. 2014 May-Jun; 28(3):353-9.
    View in: PubMed
    Score: 0.033
  8. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications. 2013 Sep-Oct; 27(5):447-53.
    View in: PubMed
    Score: 0.031
  9. Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Res Clin Pract. 2012 Jan; 95(1):e17-9.
    View in: PubMed
    Score: 0.028
  10. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technol Ther. 2011 Feb; 13(2):105-9.
    View in: PubMed
    Score: 0.026
  11. Associations among smoking status, lifestyle and lipoprotein subclasses. J Clin Lipidol. 2010 Nov-Dec; 4(6):522-30.
    View in: PubMed
    Score: 0.026
  12. Increased coated-platelet levels in chronic haemodialysis patients. Nephrology (Carlton). 2009 Apr; 14(2):148-54.
    View in: PubMed
    Score: 0.023
  13. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008 Aug; 81(2):e8-10.
    View in: PubMed
    Score: 0.022
  14. Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. J Med Invest. 2008 Feb; 55(1-2):29-36.
    View in: PubMed
    Score: 0.022
  15. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant. 2005 Nov; 20(11):2420-6.
    View in: PubMed
    Score: 0.018
  16. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Clin Sci (Lond). 2005 Jun; 108(6):497-506.
    View in: PubMed
    Score: 0.018
  17. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003 Mar; 26(3):810-8.
    View in: PubMed
    Score: 0.015
  18. Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes. BMC Ophthalmol. 2022 Apr 13; 22(1):166.
    View in: PubMed
    Score: 0.014
  19. Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis. Diabetes Care. 2022 03 01; 45(3):701-709.
    View in: PubMed
    Score: 0.014
  20. Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register. Diabetologia. 2022 02; 65(2):375-386.
    View in: PubMed
    Score: 0.014
  21. The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study. Diab Vasc Dis Res. 2021 Jul-Aug; 18(4):14791641211032547.
    View in: PubMed
    Score: 0.014
  22. FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Sci Rep. 2020 12 10; 10(1):21655.
    View in: PubMed
    Score: 0.013
  23. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
    View in: PubMed
    Score: 0.013
  24. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Res Clin Pract. 2020 Nov; 169:108450.
    View in: PubMed
    Score: 0.013
  25. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 2020 09; 43(9):2257-2265.
    View in: PubMed
    Score: 0.013
  26. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study. Diabetes Care. 2020 02; 43(2):480-483.
    View in: PubMed
    Score: 0.012
  27. Higher Serum Sex Hormone-Binding Globulin Levels Are Associated With Incident Cardiovascular Disease in Men. J Clin Endocrinol Metab. 2019 12 01; 104(12):6301-6315.
    View in: PubMed
    Score: 0.012
  28. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.
    View in: PubMed
    Score: 0.012
  29. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.
    View in: PubMed
    Score: 0.012
  30. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
    View in: PubMed
    Score: 0.012
  31. Attractions and barriers to Australian physician-researcher careers. Intern Med J. 2019 02; 49(2):171-181.
    View in: PubMed
    Score: 0.012
  32. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Diabetes Technol Ther. 2019 01; 21(1):56-58.
    View in: PubMed
    Score: 0.011
  33. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study). Metabolism. 2019 04; 93:93-99.
    View in: PubMed
    Score: 0.011
  34. Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men. PLoS One. 2018; 13(7):e0200078.
    View in: PubMed
    Score: 0.011
  35. Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. Am J Clin Nutr. 2018 06 01; 107(6):921-931.
    View in: PubMed
    Score: 0.011
  36. The association between total phthalate concentration and non-communicable diseases and chronic inflammation in South Australian urban dwelling men. Environ Res. 2017 10; 158:366-372.
    View in: PubMed
    Score: 0.010
  37. Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study. Clin Chem. 2017 Jul; 63(7):1261-1270.
    View in: PubMed
    Score: 0.010
  38. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 08; 5(8):597-609.
    View in: PubMed
    Score: 0.010
  39. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study. Diabetes Technol Ther. 2017 06; 19(6):340-348.
    View in: PubMed
    Score: 0.010
  40. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 07; 19(7):410-416.
    View in: PubMed
    Score: 0.010
  41. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.010
  42. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 12; 18(12):772-783.
    View in: PubMed
    Score: 0.010
  43. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 09; 44(9):1695-703.
    View in: PubMed
    Score: 0.010
  44. Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study. Metabolism. 2016 06; 65(6):883-92.
    View in: PubMed
    Score: 0.009
  45. Opposite associations between alanine aminotransferase and ?-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Metabolism. 2016 May; 65(5):783-793.
    View in: PubMed
    Score: 0.009
  46. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Sep; 58(9):2035-44.
    View in: PubMed
    Score: 0.009
  47. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015 Mar; 38(3):521-8.
    View in: PubMed
    Score: 0.009
  48. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Mar; 58(3):464-73.
    View in: PubMed
    Score: 0.009
  49. Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2014 Nov; 57(11):2296-303.
    View in: PubMed
    Score: 0.008
  50. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2351-8.
    View in: PubMed
    Score: 0.008
  51. Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. J Invest Dermatol. 2014 Jun; 134(6):1725-1734.
    View in: PubMed
    Score: 0.008
  52. Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial. J Diabetes Complications. 2013 Nov-Dec; 27(6):627-32.
    View in: PubMed
    Score: 0.008
  53. The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract. 2013 Jun; 100(3):e70-3.
    View in: PubMed
    Score: 0.008
  54. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4701-8.
    View in: PubMed
    Score: 0.007
  55. Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation. 2012 Oct 15; 94(7):e49-51.
    View in: PubMed
    Score: 0.007
  56. Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes. 2012 Jul; 61(7):1785-92.
    View in: PubMed
    Score: 0.007
  57. Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care. 2012 Feb; 35(2):218-25.
    View in: PubMed
    Score: 0.007
  58. LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications. 2011 Mar-Apr; 25(2):73-82.
    View in: PubMed
    Score: 0.006
  59. Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clin Biochem. 2010 Feb; 43(3):278-86.
    View in: PubMed
    Score: 0.006
  60. Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia. Med J Aust. 2009 May 18; 190(10):552-6.
    View in: PubMed
    Score: 0.006
  61. NMR-determined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract. 2009 Jan; 83(1):132-9.
    View in: PubMed
    Score: 0.006
  62. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008 Oct; 31(10):2006-12.
    View in: PubMed
    Score: 0.006
  63. Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. Eur J Cardiovasc Prev Rehabil. 2007 Jun; 14(3):413-8.
    View in: PubMed
    Score: 0.005
  64. Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic parentage. Diabetes Res Clin Pract. 2007 Apr; 76(1):119-25.
    View in: PubMed
    Score: 0.005
  65. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis. 2007 Feb; 190(2):359-69.
    View in: PubMed
    Score: 0.005
  66. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke. 2005 Oct; 36(10):2143-7.
    View in: PubMed
    Score: 0.005
  67. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation. 2005 Jul 05; 112(1):110-6.
    View in: PubMed
    Score: 0.004
  68. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005 Jan-Feb; 19(1):18-25.
    View in: PubMed
    Score: 0.004
  69. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension. 2005 Jan; 45(1):69-74.
    View in: PubMed
    Score: 0.004
  70. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 Apr; 27(4):978-83.
    View in: PubMed
    Score: 0.004
  71. Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital. J S C Med Assoc. 2002 Dec; 98(8):305-10.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.